Terms ending in 2030
Musc Foundation for Research Development
Every in-force patent on Musc Foundation for Research Development's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,911,958 | Methods for Assessing Modified LDL Immune Complexes in Subjects Having or at Risk of Coronary Artery Disease In force · Medium confidence | Department of Veterans Affairs | In force | Medium confidence | |
| US 9,260,517 | Human Monoclonal Antibodies to Human Nucleolin In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 10,385,128 | Nucleolin Antibodies In force · High confidence | Musc Foundation for Research Development | In force | High confidence | |
| US 8,409,603 | Compositions and Methods for Tissue Engineering, Tissue Regeneration and Wound Healing In force · High confidence | Musc Foundation for Research Development | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.